Long Noncoding RNA (lncRNA)-Mediated Competing Endogenous RNA Networks Provide Novel Potential Biomarkers and Therapeutic Targets for Colorectal Cancer.
Wang L, Cho KB, Li Y, Tao G, Xie Z, Guo B. · 2019
Read Long Noncoding RNA (lncRNA)-Mediated Competing Endogenous RNA Networks Provide Novel Potential Biomarkers and Therapeutic Targets for Colorectal Cancer. by Wang L, Cho KB, Li Y, Tao G, Xie Z, Guo B. (2019) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6888455.txt.
Introduction
Wang and co-authors review competing RNA networks in colorectal cancer, in the International Journal of Molecular Sciences. Colorectal cancer is the third most common cancer worldwide, and it often spreads or returns. Long noncoding RNAs help steer that progression. They can act as sponges: by soaking up microRNAs, they free the messages those microRNAs would otherwise silence.
Networks built from these three RNA kinds are called ceRNA networks. The review catalogues the ones found in colorectal cancer. They touch liver metastasis, the shift of cells into a mobile state, inflammation, and drug resistance. Because the sponges are measurable and specific, the authors propose them as biomarkers and drug targets.
Catalog record
| CREATOR | Wang L, Cho KB, Li Y, Tao G, Xie Z, Guo B. |
|---|---|
| YEAR | 2019 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 86 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Long Noncoding RNA (lncRNA)-Mediated Competing Endogenous RNA Networks Provide Novel Potential Biomarkers and Therapeutic Targets for Colorectal Cancer By Liye Wang, Kwang Bog Cho, Yan Li, Gabriel Tao, Zuoxu Xie, Bin Guo Published in: International Journal of Molecular Sciences DOI: 10.3390/ijms20225758 ABSTRACT Abstract Colorectal cancer (CRC) is the third most common cancer and has a high metastasis and reoccurrence rate. Long noncoding RNAs (lncRNAs) play an important role in CRC growth and metastasis. Recent studies revealed that lncRNAs participate in CRC progression by coordinating with microRNAs (miRNAs) and protein-coding mRNAs. LncRNAs function as competitive endogenous RNAs (ceRNAs) by competitively occupying the shared binding sequences of miRNAs, thus sequestering the miRNAs and changing the expression of their downstream target genes. Such ceRNA networks formed by lncRNA/miRNA/mRNA interactions have been found in a broad spectrum of biological processes in CRC, including liver metastasis, epithelial to mesenchymal transition (EMT), inflammation formation, and chemo-/radioresistance. In this review, we summarize typical paradigms of lncRNA-associated ceRNA networks, which are involved in the underlying molecular mechanisms of CRC initiation and progression. We comprehensively discuss the competitive crosstalk among RNA transcripts and the novel targets for CRC prognosis and therapy. Keywords: colorectal cancer, lncRNA, miRNA, ceRNA 1. INTRODUCTION Colorectal cancer (CRC) is the third most commonly diagnosed and fatal malignancy, with nearly 1.8 million new cases and almost 861,000 deaths in 2018 around the world [1]. In the past decade, the diagnosis and treatment of CRC have been greatly improved. However, distant metastasis, especially liver metastasis, and the cell stemness properties of cancer cells lead to the poor prognosis and high fatality rate in CRC patients [2]. Recent studies on the biology of noncoding RNAs in CRC and new gene therapy strategies for delivering therapeutic RNA, such as noncoding RNA or small interfering RNA (siRNA), have drawn intense interest in the investigation of long noncoding RNAs (lncRNAs) in the molecular mechanisms of CRC [3,4,5,6,7,8]. Besides the characterized lncRNAs or microRNAs (miRNAs) in important CRC-related signaling pathways, such as Wnt/β-catenin, studies in recent years have identified a novel competitive RNA network including lncRNA, miRNA, and mRNA, which mediates CRC cell proliferation, invasion, tumor growth, and metastasis. Moreover, competitive endogenous RNA (ceRNA) crosstalk has strong relevance to the acquisition of chemo-/radioresistance in CRC. Hence, deeper exploration and understanding of ceRNA mechanisms in CRC development are needed. 2. LNCRNA IN CRC LncRNAs, defined as transcripts longer than 200 nucleotides, are not translated into proteins [9]. LncRNAs, aberrantly expressed in various types of cancer cells, play a vital role in several common hallmarks of cancer [10]. In general, lncRNAs exert regulatory functions at different levels of gene expression, including chromatin modification, transcription, and post-transcription. As for chromatin modification, lncRNAs interact with chromatin remodeling complexes to induce heterochromatin formation in specific genomic loci, resulting in reduced gene expression. Moreover, lncRNAs modulate transcription by interacting with RNA-binding proteins and co-activators of transcriptional factors, or by regulating the major promoters of their target genes. Mechanically, lncRNAs exert their regulatory effects through communication with DNA, mRNAs, ncRNAs, and proteins, serving as different functional molecules, such as signals, decoys, scaffolds, and guides in various cancer-related cellular processes [11,12]. Previous studies reported that lncRNAs work mainly as signaling molecules in many important CRC-related pathways, or as scaffold guides to decoy CRC-specific protein partners, as well as a cis- and trans- regulator element for gene expression. For example, the oncogenic lncRNAs mapped to chromosome 8q.24, such as CACS11, CCAT family, and PVT1, promote CRC progression by interacting with proteins to stimulate myc or other Wnt target gene expression at the posttranslational level [13]. Furthermore, lncRNAs (Figure 1) are frequently involved in different stages of CRC from precancerous polyps to distant metastasis, which could be considered potent diagnostic biomarkers [14,15]. In recent years, increasing studies have demonstrated the existence of lncRNA-mediated competitive RNA crosstalk in CRC progression (Table 1). [Figure: Representative lncRNAs in the different stages of CRC. There are four major stages of CRC development: precancerous polys, Adenomas, Carcinoma and invasive cancer. Representative lncRNAs involved in the certain stages could be regarded as early-stage diagnostic biomarkers to evaluate CRC progression or therapeutic targets to suppress CRC metastasis.] [Table: LncRNA/miRNA/mRNA ceRNA network in CRC.] 3. THE CERNA HYPOTHESIS IN CANCERS The conventional view in the RNA field is that microRNAs (miRNAs), the short endogenous RNA ~23 nt in length, pair to the miRNA recognition elements (MREs) in the protein-coding mRNAs by partial complementarity (Figure 2A) [16]. MREs are often located in 5′ untranslated regions (5′UTRs), coding sequences (CDS), and especially in 3′ untranslated regions (3′UTRs) of various types of RNA transcripts, such as ncRNA and mRNA. Once mature miRNAs guide the miRNA-programmed RNA-induced silencing complex (miR-RISC) to MREs, the mRNA destabilization or posttranslational repression will be actively triggered, leading to the inhibition of gene expression [17]. Most miRNAs pair imperfectly with their cognate mRNAs. A target prediction algorithm has showed that the pairing of miRNA nucleotides 2-8mer to the 3′UTR of the target mRNA is often important [16]. Each miRNA is able to target numerous MREs and repress up to hundreds of transcripts. The best estimate, considering all the 2-8mer perfect and imperfect 3′UTR matches, is that over 60% of human protein-coding genes are potential targets of miRNA, highlighting the involvement of miRNA‒mRNA interaction in diseases including cancer [18,19]. However, surprisingly, many cases of miRNA-mediated regulation are modest, which repress targeted protein expression by less than 2-fold, and usually yield no consequence at a physiological level [20,21]. This discrepancy hints that a large member of RNA communication has been missing, which likely contributes to the repressive effect of miRNA. [Figure: The competitive endogenous RNA (ceRNA) mechanism. (A) In the conventional crosstalk of RNA transcripts, in the cytoplasm, miRNAs exert the suppressive function on protein-coding mRNAs by base pairing with partial complementarity via the miRNA recognition element (MREs) mapped to the 3′UTR of mRNAs. (B) Under the ceRNA mechanism in cancer cells, aberrantly expressed long noncoding RNAs (lncRNAs) with MREs competitively sequestrate miRNAs and reduce the interaction between miRNA and mRNA, and thus attenuate the repression on the downstream mRNAs.] Since miRNA repressors began to be found in plants, animals, and artificial constructs, in 2009, Seitz proposed that a large proportion of RNA transcripts with MREs act as competitive inhibitors of miRNA, so-called “miRNA sponge,” which modulate miRNA expression and function by competing for miRNA binding sites with endogenous mRNAs [20]. Experimental observations supported his theory that the noncoding 3′UTR fragment inhibited miR-199a-3p expression and its activity by acting as a sponge of miRNA [22]. Notably, the competitive endogenous RNA (ceRNA) hypothesis was proposed by Selmena et al. in 2011 [19]. They speculated that ncRNAs, particularly lncRNAs, compete for the miRNA binding sites through partial complementarity, and they named these ncRNAs ceRNAs. This interplay leads to a decrease in the miRNA level and impairment of miRNA activity. The novel ceRNA logic has been validated in Herpesvirus saimiri noncoding RNA, which manipulates host-cell gene expression by degrading mature miR-27 in a binding-dependent manner [23]. Additionally, the effectiveness of the ceRNA pathway is primarily based on the relative levels of ceRNA transcripts. Changes at the ceRNA level are critical to potentiate or attenuate the functions of miRNA on target genes because of the